Illumina (ILMN) EBT Margin (2009 - 2026)
Illumina's (ILMN) quarterly EBT Margin came in at 22.43% in Q2 2026, down 646.0% on a YoY basis from 4.11% in Q2 2025, and up 55.89% quarter-over-quarter from 14.39% in Q1 2026.
Powered by 
Analysis
Illumina (ILMN) EBT Margin (2009 - 2026) Analysis & Trends
Illumina (ILMN) has reported EBT Margin for 18 consecutive years, with 22.43% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBT Margin fell 646.0% year-over-year to 22.43%; the trailing twelve-month figure through Jun 2026 stood at 22.57% (down 999.0% YoY), and the FY2025 full-year result was 25.01%, up 5197.0% from the prior year.
- EBT Margin advanced to 22.43% in Q2 2026 per ILMN's latest filing, from 14.39% in the prior quarter.
- Across five years, EBT Margin topped out at 66.67% in Q3 2024 and bottomed at 408.43% in Q1 2023.
- Historically, EBT Margin has averaged 47.16% across 5 years, with a median of 2.14% in 2022.
- The sharpest annual moves came in 2022 and 2023: EBT Margin plunged 36723 bps in 2022, then surged 39355 bps in 2023.
- Over 5 years, EBT Margin stood at 329.33% in 2022, then surged by 95 bps to 14.88% in 2023, then soared by 214 bps to 16.94% in 2024, then jumped by 92 bps to 32.53% in 2025, then sank by 31 bps to 22.43% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 22.43%, 14.39%, and 32.53% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 16.04% |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | 17.21% |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 23.64% |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | 22.43% |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 8.71% |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 22.01% |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 83.27% |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 6.93% |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | -12.34% |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | -6.08% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 22.43% |
| Mar 29, 2026 | 14.39% |
| Dec 28, 2025 | 32.53% |
| Sep 28, 2025 | 20.30% |
| Jun 29, 2025 | 28.90% |
| Mar 30, 2025 | 17.48% |
| Dec 29, 2024 | 16.94% |
| Sep 29, 2024 | 66.67% |
| Jun 30, 2024 | -177.70% |
| Mar 31, 2024 | -10.13% |
| Dec 31, 2023 | -14.88% |
| Oct 1, 2023 | -69.88% |
| Jul 2, 2023 | -7.57% |
| Apr 2, 2023 | -7.18% |
| Jan 1, 2023 | -408.43% |
| Oct 2, 2022 | -329.33% |
| Jul 3, 2022 | -54.82% |
| Apr 3, 2022 | 11.45% |
| Oct 3, 2021 | 37.91% |
| Jul 4, 2021 | 18.38% |